Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 19, 2024

Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

HPHongwei PengYLYue LiQWQing Wan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peng et al. (2024) studied this question.

synapsesocial.com/papers/68e5fc6fb6db64358758ff35https://doi.org/10.21203/rs.3.rs-4565192/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predicting the toxicity-efficacy ratio of venetoclax in real-world patients2025
  2. 2Association between venetoclax concentration and febrile neutropenia in acute leukemia: a retrospective analysis2026
  3. 3Venetoclax concentration affects the incidence of haematological adverse events in patients with acute myeloid leukaemia2026
  4. 4Venetoclax dosages, BH3 profiling, and bcl-2 expression predict response to azacitidine + venetoclax regimen in first line AML not eligible to intensive chemotherapy: First results of venetacible study2025 · 1 citations
  5. 5Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting2026